Rock Springs Capital

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$70.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Chiasma
Oral Therapeutic Options for Patients with Rare Diseases
1 round $70.0M committed Latest: 2015-02

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Rock Springs Capital's primary sector focus?
Rock Springs Capital primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Has Rock Springs Capital had any notable exits?
Yes, Rock Springs Capital had a notable exit in July 2015 with Chiasma, which went public on NASDAQ with a valuation of $562M.
Which portfolio company has Rock Springs Capital exited?
Rock Springs Capital exited Chiasma, a company focused on oral therapeutic options for patients with rare diseases. Chiasma was acquired in 2015.
What was the funding stage of Rock Springs Capital's investment in Chiasma?
Rock Springs Capital participated in an E Round investment for Chiasma in February 2015.
When was Rock Springs Capital most active in terms of new investments?
Rock Springs Capital's most recent investment activity, according to available data, was in February 2015.